Table 2.
Sample characteristics.
| Preterm | Term | |
|---|---|---|
| Mother sample, n = 43 | ||
| Week 1 | 11 | 12 |
| Umbilical cord | 7 | 11 |
| Baby sample, n = 53 | ||
| Day 0–1 (obtained hours after birth) | 2 | 0 |
| Week 1 | 9 | 9 |
| Week 4 | 10 | 0 |
| Week 12 | 11 | 12 |
| Children vaccinated before any sample (%) | 9 (82) | 9 (75) |
| Rotatec/rotarixa | 1 | 7 |
| Prevenar 13b | 8 | 9 |
| Infanrix hexac | 9 | 9 |
| Synagisd | 1 | 0 |
| Varicellone | 1 | 0 |
aRota virus.
bPneumococci.
cDiphteria, tetanus, pertussis, hep B, polio, Hib.
dPalivizumab, immunoglobulins for respiratory synthycial virus.
eImmunoglobulin for Varicella-zoster virus.